Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Br J Nutr ; 122(8): 841-855, 2019 10 28.
Article in English | MEDLINE | ID: mdl-31217044

ABSTRACT

High-fat diet (HFD) consumption leads to metabolic disorders, gastrointestinal dysfunction and intestinal dysbiosis. Antibiotics also disrupt the composition of intestinal microbiota. The aim of the present study was to investigate the impact of a short-term feeding with HFD on oxidative status, enteric microbiota, intestinal motility and the effects of antibiotics and/or melatonin treatments on diet-induced hepato-intestinal dysfunction and inflammation. Male Sprague-Dawley rats were pair-fed with either standard chow or HFD (45 % fat) and were given tap water or melatonin (4 mg/kg per d) or melatonin plus antibiotics (ABX; neomycin, ampicillin, metronidazole; each 1 g/l) in drinking water for 2 weeks. On the 14th day, colonic motility was measured and the next day intestinal transit was assessed using charcoal propagation. Trunk blood, liver and intestine samples were removed for biochemical and histopathological evaluations, and faeces were collected for microbiota analysis. A 2-week HFD feeding increased blood glucose level and perirenal fat weight, induced low-level hepatic and intestinal inflammation, delayed intestinal transit, led to deterioration of epithelial tight junctions and overgrowth of colonic bacteria. Melatonin intake in HFD-fed rats reduced ileal inflammation, colonic motility and perirenal fat accumulation. ABX abolished increases in fat accumulation and blood glucose, reduced ileal oxidative damage, suppressed HFD-induced overgrowth in colonic bacteria, and reversed HFD-induced delay in intestinal transit; however, hepatic neutrophil accumulation, hepatic injury and dysfunction were further enhanced. In conclusion, the results demonstrate that even a short-term HFD ingestion results in hepato-intestinal inflammatory state and alterations in bacterial populations, which may be worsened with antibiotic intake, but alleviated by melatonin.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antioxidants/pharmacology , Dysbiosis/drug therapy , Intestinal Diseases/drug therapy , Liver Diseases/drug therapy , Melatonin/pharmacology , Animals , Colon/drug effects , Colon/microbiology , Colon/pathology , Diet, High-Fat/adverse effects , Disease Models, Animal , Dysbiosis/etiology , Dysbiosis/pathology , Gastrointestinal Microbiome/drug effects , Gastrointestinal Motility/drug effects , Ileum/drug effects , Ileum/microbiology , Ileum/pathology , Inflammation , Intestinal Diseases/etiology , Intestinal Diseases/pathology , Intestines/drug effects , Intestines/microbiology , Intestines/pathology , Liver/drug effects , Liver/pathology , Liver Diseases/etiology , Liver Diseases/pathology , Male , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...